|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/25 | |
| C07K 14/575 |
| (11) | Number of the document | 2152297 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08760314.8 |
| Date of filing the European patent application | 2008-05-30 | |
| (97) | Date of publication of the European application | 2010-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2015-04-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2008/056727 |
| Date | 2008-05-30 |
| (87) | Number | WO 2008/145749 |
| Date | 2008-12-04 |
| (30) | Number | Date | Country code |
| 941186 P | 2007-05-31 | US |
| (72) |
GHIGO, Ezio, IT
VAN DER LELY, Aart, Jan, NL
GRANATA, Riccarda, IT
|
| (73) |
Alizé Pharma SAS,
15, Chemin du Saquin, 69130 Ecully,
FR
|
| (54) | UNACYLATED GHRELIN AS THERAPEUTIC AGENT IN THE TREATMENT OF METABOLIC DISORDERS |
| UNACYLATED GHRELIN AS THERAPEUTIC AGENT IN THE TREATMENT OF METABOLIC DISORDERS |